Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.

"Conflicts of interest No conflicts of interest, financial or otherwise, are declared by the authors."

"Funding This work was supported by the Dutch CardioVascular Alliance (DCVA) [2012-08, 2014-11] awarded to the Phaedra and the RECONNECT consortium as well as the Impulse Grant 2018 awarded to the Phaedra IMPACT consortium. These Grants include collective funding by the Dutch Heart Foundation, Dutch Federation of University Medical Centers, The Netherlands Organization for Health Research and Development, and the Royal Netherlands Academy of Sciences. GSD is supported by a Trampoline Grant from AFM-Telethon [22379] and FOP Italia. XDM is funded by a research Grant of the Institute for CardioVascular Research (ICaR-VU) at VU University Medical Center, Amsterdam, the Netherlands."